Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 75 | 0 | 0 | 10 | 0 |
| Gross Profit | 70 | 0 | 0 | 10 | 0 |
| Operating Expenses | 640 | 830 | 1,130 | 3,060 | 3,080 |
| Operating Income | -565 | -830 | -1,130 | -3,050 | -3,080 |
| Interest Expense | 320 | 220 | 190 | 180 | 150 |
| Other Income | -5 | -180 | 20 | 60 | 100 |
| Pre-tax Income | -890 | -1,230 | -1,300 | -3,170 | -3,130 |
| Net Income Continuous | -881 | -1,004 | -1,303 | -3,177 | -3,134 |
| Net Income | $-881 | $-1,004 | $-1,303 | $-3,177 | $-3,134 |
| EPS Basic Total Ops | -327,832.20 | -327,832.20 | -393,391.60 | -852,360.20 | -852,360.20 |
| EPS Basic Continuous Ops | -327,832.20 | -327,832.20 | -393,391.60 | -852,360.20 | -852,360.20 |
| EPS Diluted Total Ops | -327,832.20 | -327,832.20 | -393,391.60 | -852,360.20 | -852,360.20 |
| EPS Diluted Continuous Ops | -327,832.20 | -327,832.20 | -393,391.60 | -852,360.20 | -852,360.20 |
| EBITDA(a) | $-535 | $-790 | $-1,380 | $-2,720 | $-3,050 |